Sodium-glucose co-transporter-2 inhibitors - empagliflozin and dapagliflozin as future therapy for Alport Syndrome, literature review
Introduction and purposes: Alport syndrome (AS) is a common hereditary kidney disorder for which there is currently no curative treatment. The current standard of care for AS involves therapeutic blockade of the renin-angiotensin-aldosterone system (RAAS). This review explores the potential of sodiu...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Nicolaus Copernicus University in Toruń,
2024-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |